Suppr超能文献

NY-ESO-1抗原的主要组织相容性复合体(MHC)I类加工过程受Rpn10和Rpn13蛋白以及非赖氨酸泛素化后的免疫蛋白酶体调控。

Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination.

作者信息

Golnik Richard, Lehmann Andrea, Kloetzel Peter-Michael, Ebstein Frédéric

机构信息

From the Institute for Biochemistry, Charité-Universitätsmedizin Berlin, Charité Platz 1/Virchowweg 6, 10117 Berlin, Germany.

From the Institute for Biochemistry, Charité-Universitätsmedizin Berlin, Charité Platz 1/Virchowweg 6, 10117 Berlin, Germany

出版信息

J Biol Chem. 2016 Apr 15;291(16):8805-15. doi: 10.1074/jbc.M115.705178. Epub 2016 Feb 22.

Abstract

The supply of MHC class I-restricted peptides is primarily ensured by the degradation of intracellular proteins via the ubiquitin-proteasome system. Depending on the target and the enzymes involved, ubiquitination is a process that may dramatically vary in terms of linkages, length, and attachment sites. Here we identified the unique lysine residue at position 124 of the NY-ESO-1 cancer/testis antigen as the acceptor site for the formation of canonical Lys-48-linkages. Interestingly, a lysine-less form of NY-ESO-1 was as efficient as its wild-type counterpart in supplying the HLA-A*0201-restricted NY-ESO-1157-165 antigenic peptide. In fact, we show that the regulation of NY-ESO-1 processing by the ubiquitin receptors Rpn10 and Rpn13 as a well as by the standard and immunoproteasome is governed by non-canonical ubiquitination on non-lysine sites. In summary, our data underscore the significance of atypical ubiquitination in the modulation of MHC class I antigen processing.

摘要

主要组织相容性复合体(MHC)I类限制性肽的供应主要通过泛素 - 蛋白酶体系统对细胞内蛋白质的降解来确保。根据靶标和所涉及的酶,泛素化是一个在连接方式、长度和附着位点方面可能有显著差异的过程。在这里,我们确定了NY-ESO-1癌胚抗原第124位独特的赖氨酸残基是形成典型的赖氨酸48连接的接受位点。有趣的是,一种无赖氨酸形式的NY-ESO-1在提供HLA-A*0201限制性NY-ESO-1157-165抗原肽方面与其野生型对应物一样有效。事实上,我们表明泛素受体Rpn10和Rpn13以及标准蛋白酶体和免疫蛋白酶体对NY-ESO-1加工的调节是由非赖氨酸位点上的非典型泛素化控制的。总之,我们的数据强调了非典型泛素化在调节MHC I类抗原加工中的重要性。

相似文献

3
5
Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.
Cancer Res. 2005 Nov 1;65(21):10041-9. doi: 10.1158/0008-5472.CAN-05-1383.
6
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
J Immunol. 2000 Jul 15;165(2):948-55. doi: 10.4049/jimmunol.165.2.948.
7
Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing.
Eur J Immunol. 2015 Mar;45(3):716-27. doi: 10.1002/eji.201444830. Epub 2015 Jan 15.

引用本文的文献

1
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation.
Front Immunol. 2025 Aug 1;16:1636951. doi: 10.3389/fimmu.2025.1636951. eCollection 2025.
2
Deciphering non-canonical ubiquitin signaling: biology and methodology.
Front Mol Biosci. 2024 Feb 13;10:1332872. doi: 10.3389/fmolb.2023.1332872. eCollection 2023.
4
Thioester and Oxyester Linkages in the Ubiquitin System.
Methods Mol Biol. 2023;2602:3-18. doi: 10.1007/978-1-0716-2859-1_1.
5
Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
Pathol Oncol Res. 2021 Oct 29;27:1609941. doi: 10.3389/pore.2021.1609941. eCollection 2021.
7
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.
PLoS One. 2021 Sep 10;16(9):e0256937. doi: 10.1371/journal.pone.0256937. eCollection 2021.
8
The Ubiquitin-Proteasome System in Immune Cells.
Biomolecules. 2021 Jan 5;11(1):60. doi: 10.3390/biom11010060.
9
Bacterial virulence mediated by orthogonal post-translational modification.
Nat Chem Biol. 2020 Oct;16(10):1043-1051. doi: 10.1038/s41589-020-0638-2. Epub 2020 Sep 17.
10
A Cycle of Ubiquitination Regulates Adaptor Function of the Nedd4-Family Ubiquitin Ligase Rsp5.
Curr Biol. 2020 Feb 3;30(3):465-479.e5. doi: 10.1016/j.cub.2019.11.086. Epub 2020 Jan 16.

本文引用的文献

1
Reversible 26S proteasome disassembly upon mitochondrial stress.
Cell Rep. 2014 Jun 12;7(5):1371-1380. doi: 10.1016/j.celrep.2014.04.030. Epub 2014 May 22.
2
Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates.
EMBO J. 2014 May 16;33(10):1159-76. doi: 10.1002/embj.201386906. Epub 2014 May 8.
3
Re-examining class-I presentation and the DRiP hypothesis.
Trends Immunol. 2014 Apr;35(4):144-52. doi: 10.1016/j.it.2014.01.002. Epub 2014 Feb 21.
4
The complexity of recognition of ubiquitinated substrates by the 26S proteasome.
Biochim Biophys Acta. 2014 Jan;1843(1):86-96. doi: 10.1016/j.bbamcr.2013.07.007. Epub 2013 Jul 18.
5
The ubiquitin code.
Annu Rev Biochem. 2012;81:203-29. doi: 10.1146/annurev-biochem-060310-170328. Epub 2012 Apr 10.
6
The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.
Cell Mol Life Sci. 2012 Jul;69(14):2443-54. doi: 10.1007/s00018-012-0933-5. Epub 2012 Feb 19.
7
Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
Cell Mol Life Sci. 2011 May;68(9):1481-9. doi: 10.1007/s00018-011-0656-z. Epub 2011 Mar 17.
8
The role of the proteasome in the generation of MHC class I ligands and immune responses.
Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9.
9
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease.
J Biol Chem. 2011 Mar 25;286(12):10457-65. doi: 10.1074/jbc.M110.149633. Epub 2011 Jan 28.
10
Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones.
Neurosci Lett. 2011 Mar 10;491(1):44-7. doi: 10.1016/j.neulet.2010.12.064. Epub 2011 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验